Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Amnolake (tamibarotene)
i
Other names:
SY-1425, INNO 507, RR 110, TM‑411, TOS-80T, Z-208, OMS0728, AM‑80, OP-09, NSC-608000
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Nippon Shinyaku, Ohara Pharma, RaQualia, Syros, Zeria Pharma
Drug class:
RARα agonist
‹
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
RARA positive
Acute Myelogenous Leukemia
RARA positive
Acute Myelogenous Leukemia
tamibarotene
Sensitive: C3 – Early Trials
tamibarotene
Sensitive
:
C3
tamibarotene
Sensitive: C3 – Early Trials
tamibarotene
Sensitive
:
C3
RARA overexpression
Acute Myelogenous Leukemia
RARA overexpression
Acute Myelogenous Leukemia
azacitidine + tamibarotene
Sensitive: C3 – Early Trials
azacitidine + tamibarotene
Sensitive
:
C3
azacitidine + tamibarotene
Sensitive: C3 – Early Trials
azacitidine + tamibarotene
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login